Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ashley C. Godwin
Regulatory and Clinical Experiences With Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Pcp67 - Regulatory Requirements and Scientific Rationale for Biosimilar: Us vs. European Union.
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quality Comparison of Biosimilar and Copy Filgrastim Products With the Innovator Product
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Trademark Use Doctrine in the European Union and Japan
SSRN Electronic Journal
Institutionalization of Strategic Partnerships : Comparative Analysis of Established European Union Partnerships With the United States, Japan and Canada
Athenaeum Polskie Studia Politologiczne
Filgrastim-SNDZ Debuts as the First Biosimilar Approved in United States
Journal of Community and Supportive Oncology
Oncology
Hematology
Cross-Border Teaching Experiences in Canada and the U.S.: A Writing Teacher Reflects
Canadian Journal for Studies in Discourse and Writing/Rédactologie
Comparison of the Pharmacodynamic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Environmental Leadership? Comparing Regulatory Outcomes and Industrial Performance in the United States and the European Union
Journal of Cleaner Production
Industrial
Environmental Science
Renewable Energy
Manufacturing Engineering
Strategy
Sustainability
Management
the Environment
